Latest filing published 06 Oct 2008 for Champions Oncology, INC., €617.
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +37.3%Entry US$6.12 · Close at T+365 US$8.40
- +7.7%Entry US$7.80 · Close at T+365 US$8.40
- -17.6%Entry US$10.20 · Close at T+365 US$8.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Douglas D. Burkett: trading record in brief
Douglas D. Burkett is a declared insider at 2 companies; the most frequent names are Zila Inc and Champions Oncology, Inc. Between 14 December 2006 and 3 October 2008, the trades on record add up to 10 filings.
The open-market record is one-sided, with 9 purchases worth €41k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. So far in 2008, the count stands at 3 purchases and no sales.
In size, the median ticket on the buying side is €1,070. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +56.9%. These figures describe past trades and do not predict future prices.
On 6 October 2008 came the latest disclosure, an open-market purchase for €617 in Champions Oncology, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Douglas D. Burkett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$0.85Common StockSEC:0001191598-08-000007:0Canonical exit: 1 Jan 2009 (T+90)
- 1,500 shares@ US$1.00Common StockSEC:0001191598-08-000005:0Canonical exit: 29 Dec 2008 (T+90)
- 1,500 shares@ US$1.00Common StockSEC:0001191598-08-000004:0Canonical exit: 23 Dec 2008 (T+90)
- 100,000 shares0Common StockSEC:0001341522-06-000036:0
- 5,270 shares@ US$2.64Common StockSEC:0001341522-06-000036:1Canonical exit: 18 Mar 2007 (T+90)
- 100 shares@ US$2.62Common StockSEC:0001341522-06-000036:2Canonical exit: 18 Mar 2007 (T+90)
- 500 shares@ US$2.57Common StockSEC:0001341522-06-000036:3Canonical exit: 18 Mar 2007 (T+90)
- 8,850 shares@ US$2.60Common StockSEC:0001341522-06-000036:4Canonical exit: 18 Mar 2007 (T+90)
- 2,250 shares@ US$2.59Common StockSEC:0001341522-06-000036:5Canonical exit: 18 Mar 2007 (T+90)
- 2,200 shares@ US$2.61Common StockSEC:0001341522-06-000036:6Canonical exit: 18 Mar 2007 (T+90)
10 of 10 declarations
